Amedeo Smart

Free Medical Literature Service


 

Amedeo

Otorhinolaryngology

  Free Subscription

Articles published in
Radiother Oncol
    October 2021
  1. BROOKER RC, Antczak P, Liloglou T, Risk JM, et al
    Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy.
    Radiother Oncol. 2021;165:87-93.
    >> Share

  2. CHIN O, Yu E, O'Sullivan B, Su J, et al
    Prognostic Importance of Radiologic Extranodal Extension in Nasopharyngeal Carcinoma Treated in a Canadian Cohort.
    Radiother Oncol. 2021 Oct 27. pii: S0167-8140(21)08785.
    >> Share

  3. ZHANG ZM, Zhao R, Bao Y, Zhou LX, et al
    A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08758.
    >> Share

  4. SHI Z, Zhu X, Ke S, Qiu H, et al
    Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: a propensity score matching and landmark analyses.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08754.
    >> Share

  5. YAN A, Hanna A, Wilson TG, Deraniyagala R, et al
    Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)08748.
    >> Share

  6. KANEHIRA T, van Kranen S, Jansen T, Hamming-Vrieze O, et al
    Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)06738.
    >> Share

    September 2021
  7. HUANG W, Zhang Q, Wu G, Pian Chen P, et al
    DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
    Radiother Oncol. 2021 Sep 27. pii: S0167-8140(21)06739.
    >> Share

  8. WAGENAAR D, Schuit E, van der Schaaf A, Langendijk JA, et al
    Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06723.
    >> Share

  9. WANG X, Hobbs B, Gandhi SJ, Muijs CT, et al
    Current Status and Application of Proton Therapy for Esophageal Cancer.
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06724.
    >> Share

  10. CHOW JCH, Lee A, Bao KKH, Cheung KM, et al
    Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.
    Radiother Oncol. 2021 Sep 7. pii: S0167-8140(21)06716.
    >> Share

    August 2021
  11. KROESE TE, Jairam J, Ruurda JP, Lin SH, et al
    Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: incidence and external validation of a prediction model.
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06703.
    >> Share

  12. LIU T, Liu LT, Lin JY, Shen BW, et al
    Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06704.
    >> Share

  13. WENTZEL A, Luciani T, van Dijk LV, Taku N, et al
    Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas.
    Radiother Oncol. 2021;161:152-158.
    >> Share

  14. N B P, Ravi KS, Durgapal P
    Discovery of new salivary gland - A substantial histological analysis.
    Radiother Oncol. 2021;161:92-94.
    >> Share

  15. GREGOIRE V, Bauwens L
    Reply to sanguineti regarding the manuscript untitled "Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma".
    Radiother Oncol. 2021;161:253.
    >> Share

  16. SANGUINETI G
    Re: Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol, 2021. 157: p. 122-129.
    Radiother Oncol. 2021;161:251-252.
    >> Share

    July 2021
  17. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Corrigendum to "Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: Proposed modification in the current UICC/AJCC staging system" [Radiother Oncol 160 (2021) 221-227].
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06644.
    >> Share

  18. YANG G, Feng D, Li F, Luo B, et al
    A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06667.
    >> Share

  19. PARSAI S, Lei J Qiu R, Qi P, Sedor G, et al
    In Vivo Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology Implementation.
    Radiother Oncol. 2021 Jul 29. pii: S0167-8140(21)06666.
    >> Share

  20. AL-MAMGANI A, Kessels R, Navran A, Hamming-Vrieze O, et al
    Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes.
    Radiother Oncol. 2021 Jul 23. pii: S0167-8140(21)06659.
    >> Share

  21. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06639.
    >> Share

  22. MUNARETTO TIMM BAIOCCHI J, Fischer-Sgrott F, Baiocchi Neto G
    Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06642.
    >> Share

  23. JO YY, Yu J, Song KJ, Jang JY, et al
    Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: a retrospective study.
    Radiother Oncol. 2021 Jul 12. pii: S0167-8140(21)06643.
    >> Share

  24. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06626.
    >> Share

  25. VAN DER LAAN HP, van der Schaaf A, Van den Bosch L, Korevaar EW, et al
    Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06623.
    >> Share

  26. CAO J, Zhang X, Jiang B, Chen J, et al
    Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
    Radiother Oncol. 2021;160:32-39.
    >> Share

    June 2021
  27. SUN XS, Xie SY, Luo DH, Liu LT, et al
    Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016.
    Radiother Oncol. 2021 Jun 25. pii: S0167-8140(21)06612.
    >> Share

  28. DONNELLY O, Goranova R, Nugent M
    Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
    Radiother Oncol. 2021 Jun 15. pii: S0167-8140(21)06579.
    >> Share

  29. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06581.
    >> Share

  30. JIN YN, Yao JJ, You YF, Cao HJ, et al
    Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
    Radiother Oncol. 2021 Jun 8. pii: S0167-8140(21)06575.
    >> Share

  31. DE BREE R, Swartz JE, Bril S, Chargi N, et al
    Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients.
    Radiother Oncol. 2021 Jun 6. pii: S0167-8140(21)06573.
    >> Share

    May 2021
  32. JIANG C, Gong B, Gao H, Zhang T, et al
    Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).
    Radiother Oncol. 2021 May 24. pii: S0167-8140(21)06258.
    >> Share

  33. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Radiother Oncol. 2021 May 13. pii: S0167-8140(21)06241.
    >> Share

  34. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Extent of Paranasal Sinus Involvement and its Prognostic Value in Nasopharyngeal Carcinoma: Proposed Modification in the Current UICC/AJCC staging system.
    Radiother Oncol. 2021 May 10. pii: S0167-8140(21)06224.
    >> Share

  35. SUN Z, Hu S, Xue Q, Jin L, et al
    Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?
    Radiother Oncol. 2021 May 2. pii: S0167-8140(21)06214.
    >> Share

    April 2021
  36. TAMBAS M, der Laan HPV, Rutgers W, van den Hoek JGM, et al
    Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06194.
    >> Share

  37. VAN DER LAAN HP, Van den Bosch L, Schuit E, Steenbakkers RJHM, et al
    aImpact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06193.
    >> Share

  38. ELICIN O, Koller Brolese E, Bojaxhiu B, Sermaxhaj B, et al
    The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer.
    Radiother Oncol. 2021 Apr 10. pii: S0167-8140(21)06185.
    >> Share

  39. ESTEBAN B, Pierre P, Camille S, Pascal P, et al
    Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: a multicentric study using propensity score.
    Radiother Oncol. 2021 Apr 9. pii: S0167-8140(21)06183.
    >> Share

  40. LU ZJ, Liu LT, Sun XS, Guo SS, et al
    Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06175.
    >> Share

  41. YAN JJ, Guo SS, Lin DF, Liu LT, et al
    Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06180.
    >> Share

  42. QIU Y, Guo Z, Lin X, Li J, et al
    Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06179.
    >> Share

  43. ZHANG Y, Feng W, Gao LT, Cai XW, et al
    Long-term follow-up of a phase I/II trial of radiation dose escalation by simultaneous integrated boost for locally advanced esophageal squamous cell carcinoma.
    Radiother Oncol. 2021 Apr 1. pii: S0167-8140(21)06171.
    >> Share

  44. WONG ET, Huang SH, O'Sullivan B, Persaud V, et al
    Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
    Radiother Oncol. 2021;157:255-262.
    >> Share

  45. JENSEN GL, Axelrud G, Fink D, Hammonds K, et al
    Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT.
    Radiother Oncol. 2021;157:234-240.
    >> Share

  46. BAUWENS L, Baltres A, Fiani DJ, Zrounba P, et al
    Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2021;157:122-129.
    >> Share

  47. MEN K, Chen X, Yang B, Zhu J, et al
    Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning.
    Radiother Oncol. 2021;157:1-7.
    >> Share

    March 2021
  48. LI G, Jiang Y, Li G, Qiao Q, et al
    Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Mar 25. pii: S0167-8140(21)06143.
    >> Share

  49. LOSER A, Abel J, Magdalena Kutz L, Krause L, et al
    Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: results from the prospective randomized headnut-trial.
    Radiother Oncol. 2021 Mar 22. pii: S0167-8140(21)06145.
    >> Share

  50. RUHLE A, Grosu AL, Wiedenmann N, Stoian R, et al
    Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
    Radiother Oncol. 2021 Mar 19. pii: S0167-8140(21)06140.
    >> Share

  51. GROSSBERG AJ, Rock CD, Edwards J, Mohamed ASR, et al
    Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2021 Mar 15. pii: S0167-8140(21)06131.
    >> Share

  52. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
    Radiother Oncol. 2021 Mar 9. pii: S0167-8140(21)06117.
    >> Share

  53. CHEN B, Deng M, Yang C, Dragomir MP, et al
    High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06094.
    >> Share

  54. BROLESE EK, Cihoric N, Bojaxhiu B, Sermaxhaj B, et al
    The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06113.
    >> Share

  55. HOSNI A, Huang SH, Xu W, Su J, et al
    Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.
    Radiother Oncol. 2021;156:95-101.
    >> Share

    February 2021
  56. HUANG TW, Shao CH, Chiang CC
    Response to the letter to the editor "Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials regards to Chiu et al."
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06086.
    >> Share

  57. CHIU YH, Wang TG
    Letter to the editor regarding Shao et al., Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06088.
    >> Share

  58. FAN WJ, Teng F, Liu G, Zhao DW, et al
    Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06050.
    >> Share

  59. NIE D, Wang X, Sun M, Feng Z, et al
    The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06047.
    >> Share

  60. YANG ES, Deutsch E, Mehmet A, Fayette J, et al
    A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Feb 9. pii: S0167-8140(21)06040.
    >> Share

  61. VAN AKEN ESM, Paul van der Laan H, Bijl HP, Van den Bosch L, et al
    Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06023.
    >> Share

  62. VAN DEN BOSCH L, van der Schaaf A, Paul van der Laan H, Hoebers FJP, et al
    Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06021.
    >> Share

  63. MICHAELIDOU A, Adjogatse D, Suh Y, Pike L, et al
    18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO).
    Radiother Oncol. 2021;155:261-268.
    >> Share

  64. ROSEN BS, Wilkie JR, Sun Y, Ibrahim M, et al
    CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Radiother Oncol. 2021;155:174-181.
    >> Share

    January 2021
  65. MAO Y, Wang S, Lydiatt W, Shah JP, et al
    Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
    Radiother Oncol. 2021 Jan 28. pii: S0167-8140(21)00015.
    >> Share

  66. LACAS B, Carmel A, Landais C, Wong SJ, et al
    Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00013.
    >> Share

  67. WEN DW, Lin L, Mao YP, Chen CY, et al
    Comparison of Normal Tissue Complication Probability (NTCP) Models Using Machine Learning for Predicting Temporal Lobe Injury after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: a Large Registry-Based Retrospective Study from China.
    Radiother Oncol. 2021 Jan 20. pii: S0167-8140(21)00008.
    >> Share

  68. HUANG TT, Li SH, Chen YH, Lu HI, et al
    Definitive chemoradiotherapy for clinical T4b esophageal cancer - treatment outcomes, failure patterns, and prognostic factors.
    Radiother Oncol. 2021 Jan 19. pii: S0167-8140(21)00007.
    >> Share

  69. GUO Q, Zheng Y, Lin J, Xu Y, et al
    Modified Reduced-volume Intensity-modulated radiation therapy in Non-metastatic Nasopharyngeal Carcinoma: A Prospective Observation Series.
    Radiother Oncol. 2021 Jan 5. pii: S0167-8140(20)31262.
    >> Share

  70. QIU X, Xu T, Li M, Fei Z, et al
    Response to Chai' letter: What caused the difference in prognosis among different physicians?
    Radiother Oncol. 2021;154:e20-e21.
    >> Share

    December 2020

  71. Salivary glands at the pharyngeal ostium of the Eustachian tube are already described in histological literature.
    Radiother Oncol. 2020 Dec 30. pii: S0167-8140(20)31248.
    >> Share

  72. FAN KH, Yeh CH, Hung SP, Kang CJ, et al
    Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
    Radiother Oncol. 2020 Dec 29. pii: S0167-8140(20)31255.
    >> Share

  73. XIANG M, Gensheimer MF, Pollom EL, Holsinger FC, et al
    Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
    Radiother Oncol. 2020 Dec 28. pii: S0167-8140(20)31251.
    >> Share

  74. LIANG SB, Chen LS, Chen HY, Yang XL, et al
    Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: a retrospective study.
    Radiother Oncol. 2020 Dec 10. pii: S0167-8140(20)31231.
    >> Share

    November 2020
  75. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31193.
    >> Share

  76. LIANG SB, Chen LS, Yang XL, Chen DM, et al
    Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.
    Radiother Oncol. 2020 Nov 17. pii: S0167-8140(20)31165.
    >> Share

  77. HIROSE K, Konno A, Hiratsuka J, Yoshimoto S, et al
    Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.
    Radiother Oncol. 2020 Nov 10. pii: S0167-8140(20)30890.
    >> Share

  78. YANG HC, Wu CC, Lee CC, Huang HE, et al
    Prediction of Pseudoprogression and Long-term Outcome of Vestibular Schwannoma after Gamma Knife Radiosurgery based on Preradiosurgical MR Radiomics.
    Radiother Oncol. 2020 Nov 5. pii: S0167-8140(20)30888.
    >> Share

    October 2020
  79. CHEN NB, Li QW, Li S, Guo SP, et al
    Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021).
    Radiother Oncol. 2020 Oct 31. pii: S0167-8140(20)30882.
    >> Share

  80. ZSCHAECK S, Zophel K, Seidlitz A, Zips D, et al
    Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
    Radiother Oncol. 2020;155:204-211.
    >> Share

  81. VAN ROSSUM PSN, Jeene PM, Rozema T, Braam PM, et al
    Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30845.
    >> Share

  82. LUO WJ, Zou WQ, Liang SB, Chen L, et al
    Combining tumor response and personalized risk assessment: potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30841.
    >> Share

  83. HAMILTON SN, Urban R, Liu A, Chau N, et al
    Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer.
    Radiother Oncol. 2020;151:110-117.
    >> Share

  84. LAI TY, Yeh CM, Hu YW, Liu CJ, et al
    Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy.
    Radiother Oncol. 2020;151:190-199.
    >> Share

  85. SHARMA MB, Jensen K, Urbak SF, Funding M, et al
    A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer.
    Radiother Oncol. 2020;151:58-65.
    >> Share

    September 2020
  86. LI J, Wen Y, Xiang Z, Du H, et al
    Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.
    Radiother Oncol. 2020 Sep 24. pii: S0167-8140(20)30817.
    >> Share

    July 2020
  87. WENTZEL A, Hanula P, van Dijk LV, Elgohari B, et al
    Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.
    Radiother Oncol. 2020;148:245-251.
    >> Share

  88. GRANT SR, Hutcheson KA, Ye R, Garden AS, et al
    Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Radiother Oncol. 2020;148:133-139.
    >> Share

    June 2020
  89. MANZAR GS, Lester SC, Routman DM, Harmsen WS, et al
    Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
    Radiother Oncol. 2020;147:64-74.
    >> Share

    April 2020
  90. DE FELICE F, Bird T, Michaelidou A, Thavaraj S, et al
    Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    Radiother Oncol. 2020;145:146-153.
    >> Share

  91. NG SP, Bahig H, Jethanandani A, Pollard C, et al
    Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
    Radiother Oncol. 2020;145:95-100.
    >> Share

    March 2020
  92. HUANG SH, O'Sullivan B, Su J, Bartlett E, et al
    Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
    Radiother Oncol. 2020;144:13-22.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016